| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.6B | $6.0B | $5.6B | $5.1B | $5.3B | $4.8B | $5.2B | $5.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.7B | $0.7B | $0.7B | $0.7B | $0.7B | $0.6B | $0.6B | $0.6B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.0B | $1.1B | $0.4B | $0.2B | $0.6B | $-0.1B | $0.3B | $0.0B |
| EPS (Basic) | $12.52 | $12.49 | $4.06 | $2.27 | $6.95 | $-0.06 | $-0.12 | $-2.37 |
| EPS (Diluted) | $12.35 | $12.35 | $4.02 | $2.25 | $6.90 | $-0.06 | $-0.12 | $-2.37 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $34.5B | $32.5B | $30.3B | $27.6B | $27.4B | $25.9B | $25.6B | $24.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.8B | $2.1B | $1.0B | $0.8B | $0.8B | $0.9B | $1.2B | $1.2B |
| Total Liabilities | $28.1B | $26.4B | $25.0B | $23.0B | $22.0B | $20.6B | $20.1B | $19.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $6.4B | $6.1B | $5.3B | $4.6B | $5.4B | $5.3B | $5.5B | $5.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.0B | $1.8B | $1.3B | $0.7B | $1.1B | $0.3B | $0.2B | $0.0B |
| Investing Cash Flow | $-0.6B | $0.3B | $-0.9B | $-0.7B | $-1.1B | $0.5B | $-0.8B | $0.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.1B | $-0.4B | $-0.2B | $-0.1B | $-0.2B | $-0.9B | $0.3B | $-0.2B |